Biotech Late Stage Investors & VC Firms
652 firms in this list, with a median first check of $1M. 131 of them lead rounds. Generated from verified public data and updated continuously.
Pappas Capital
Research Triangle ParkSeed–Late Stage$100K – $6M
15 people
Cowin Capital Group
ShenzhenSeed–Late Stage$1.4M – $50M
11 people
Grazia Equity GmbH
StuttgartSeed–Late Stage$540K – $2.7M
8 people
Revelation Partners
SausalitoGrowth–Late Stage$5M – $50M
16 people
Bridge Bank
San FranciscoSeed–Late Stage
18 people
Tullis Health Investors
Palm Beach GardensSeries A–Late Stage$500K – $10M
12 people
Clay Capital
Seed–Late Stage$3M – $8M
16 people
California Technology Ventures
PasadenaSeed–Late Stage$250K – $2M
3 people
iGan Partners
TorontoSeed–Late Stage$365K – $2.2M
9 people
Hikma Ventures
LondonSeed–Late Stage$5M
14 people
Quadrille Capital
ParisSeed–Late Stage
14 people
IDG Capital Vietnam
HanoiSeed–Late Stage$250K – $3M
13 people
Ligand Pharmaceuticals
JupiterLate Stage$10M – $50M
16 people
Korea Investment Partners
SeoulSeed–Late Stage$973K – $50M
17 people
Innovatus Capital Partners
New YorkSeed–Late Stage
19 people
Intermediate Capital Group
LondonGrowth–Late Stage$5M – $50M
16 people
Maxpro Ventures
TaipeiSeed–Late Stage$10M – $13M
7 people
Kelvin Capital
GlasgowSeed–Late Stage
8 people
SCP Vitalife Partners
Tel AvivSeed–Late Stage$3M – $7M
11 people
PAI Partners
ParisGrowth–Late Stage$108M – $324M
13 people
Perscitus LLP
LondonPre-Seed–Late Stage
10 people
Hongtai Capital Holdings
BeijingSeed–Late Stage
INCE Capital
ShanghaiSeed–Late Stage
9 people
Black Diamond Ventures
GlendalePre-Seed–Late Stage$2M – $10M
14 people
Related lists
Late Stage Investors & VC Firms (2974)Biotech Investors & VC Firms (2185)Biotech Seed Investors & VC Firms (1824)Late Stage Investors & VC Firms in North America (1695)Biotech Series A Investors & VC Firms (1668)Late Stage Investors & VC Firms in United States (1516)Biotech Investors & VC Firms in North America (1391)Biotech Investors & VC Firms in United States (1267)Late Stage Investors & VC Firms in Europe (965)Biotech Pre-Seed Investors & VC Firms (957)
Data sourced from public filings and firms' own websites — see our methodology.















































































